Literature DB >> 29721957

Müller Glia Reactivity and Development of Gliosis in Response to Pathological Conditions.

Anna B Graca1, Claire Hippert2, Rachael A Pearson3.   

Abstract

Within the mammalian retina, both Müller glia and astrocytes display reactivity in response to many forms of retinal injury and disease in a process termed gliosis. Reactive gliosis is a complex process that is considered to represent a cellular response to protect the retina from further damage and to promote its repair following pathological insult. It includes morphological, biochemical and physiological changes, which may vary depending on the type and degree of the initial injury. Not only does gliosis have numerous triggers, but also there is a great degree of heterogeneity in the glial response, creating multiple levels of complexity. For these reasons, understanding the process of glial scar formation and how this process differs in different pathological conditions and finding strategies to circumvent these barriers represent major challenges to the advancement of many ocular therapies.

Entities:  

Keywords:  Glial hypertrophy; Gliosis; Intermediate filament proteins; Müller glia; Retinal diseases; Retinal remodelling

Mesh:

Substances:

Year:  2018        PMID: 29721957     DOI: 10.1007/978-3-319-75402-4_37

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Regenerative capacity of Müller cells and their modulation as a tool to treat retinal degenerations.

Authors:  Federica M Conedera; Volker Enzmann
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

2.  Absence of ephrin-A2/A3 increases retinal regenerative potential for Müller cells in Rhodopsin knockout mice.

Authors:  Rui-Lin Zhu; Yuan Fang; Hong-Hua Yu; Dong F Chen; Liu Yang; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

Review 3.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

4.  Analysis of multiple cytokines in aqueous humor of patients with idiopathic macular hole.

Authors:  Heping Wang; Yuqi Li; Song Han; Tongtong Niu
Journal:  BMC Ophthalmol       Date:  2021-01-11       Impact factor: 2.209

Review 5.  AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy.

Authors:  Simon J O'Carroll; William H Cook; Deborah Young
Journal:  Front Mol Neurosci       Date:  2021-01-11       Impact factor: 5.639

6.  The TGFβ/Notch axis facilitates Müller cell-to-epithelial transition to ultimately form a chronic glial scar.

Authors:  Federica Maria Conedera; Ana Maria Quintela Pousa; Nadia Mercader; Markus Tschopp; Volker Enzmann
Journal:  Mol Neurodegener       Date:  2021-09-30       Impact factor: 14.195

7.  Excitatory neurotransmission activates compartmentalized calcium transients in Müller glia without affecting lateral process motility.

Authors:  Joshua M Tworig; Chandler J Coate; Marla B Feller
Journal:  Elife       Date:  2021-12-16       Impact factor: 8.140

8.  Rapamycin and Resveratrol Modulate the Gliotic and Pro-Angiogenic Response in Müller Glial Cells Under Hypoxia.

Authors:  Paula V Subirada; María V Vaglienti; Mariana B Joray; María C Paz; Pablo F Barcelona; María C Sánchez
Journal:  Front Cell Dev Biol       Date:  2022-03-01

9.  Combined Transplantation of Olfactory Ensheathing Cells With Rat Neural Stem Cells Enhanced the Therapeutic Effect in the Retina of RCS Rats.

Authors:  Wei Zhai; Lixiong Gao; Linghui Qu; Yijian Li; Yuxiao Zeng; Qiyou Li; Haiwei Xu; Zheng Qin Yin
Journal:  Front Cell Neurosci       Date:  2020-03-24       Impact factor: 5.505

10.  YAP is essential for TGF-β-induced retinal fibrosis in diabetic rats via promoting the fibrogenic activity of Müller cells.

Authors:  Wei Zhang; Yichun Kong
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.